Clinical Applications of Brachytherapy Radiobiology. Radiobiology is Essential

Similar documents
Fractionation: why did we ever fractionate? The Multiple Fractions School won! Survival curves: normal vs cancer cells

The Four R s. Repair Reoxygenation Repopulation Redistribution. The Radiobiology of Small Fraction Numbers. The Radiobiology of Small Fraction Numbers

BASIC CLINICAL RADIOBIOLOGY

Radiobiological principles of brachytherapy

Pavel ŠLAMPA, Jana RUZICKOVA, Barbora ONDROVA, Hana TICHA, Hana DOLEZELOVA

Definitions. Brachytherapy in treatment of cancer. Implantation Techniques and Methods of Dose Specifications. Importance of Brachytherapy in GYN

Brachytherapy Planning and Quality Assurance w Classical implant systems and modern computerized dosimetry w Most common clinical applications w

Brachytherapy Planning and Quality Assurance

HDR vs. LDR Is One Better Than The Other?

Radiation Damage Comparison between Intensity Modulated Radiotherapy (IMRT) and Field-in-field (FIF) Technique In Breast Cancer Treatments

Accelerated Partial Breast Irradiation. Dr Patricia Lillis MD, MHA,MSS Marshfield Clinic Radiation Oncology

Radiobiological Models in Brachytherapy Planning and Evaluation


NSABP PROTOCOL B-39B RTOG PROTOCOL 0413

HDR Applicators and Dosimetry*

7/16/2009. An overview of classical radiobiology. Radiobiology and the cell kill paradigm. 1. Repair: Radiation cell killing. Radiation cell killing

The Radiation Biology of Dose Fractionation: Determinants of Effect

The Paul Evans Memorial Lecture Functional radiotherapy targeting using focused dose escalation. Roberto Alonzi Mount Vernon Cancer Centre

Breast Conservation Therapy

Use of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation.

Comparison of two techniques of interstitial pulsed dose rate boost brachytherapy in conservative treatment of breast cancer

Review of brachytherapy in

Isoeffective Dose Specification of Normal Liver in Yttrium-90 Microsphere Radioembolization*

Comprehensive and Practical Brachytherapy March 04-8 March 2018, Ljubljana, Slovenia Day 1 Sunday 4 March 2018

HDR Brachytherapy: Results and Future Studies in Monotherapy

High-Dose-Rate Orthogonal Intracavitary Brachytherapy with 9 Gy/Fraction in Locally Advanced Cervical Cancer: Is it Feasible??

Brachytherapy is better than external beam therapy for partial breast irradiation

Hypofractionated Radiotherapy for breast cancer: Updated evidence

Evaluation of three APBI techniques under NSABP B-39 guidelines

Commissioning and Radiobiology of the INTRABEAM System

Radiotherapy physics & Equipments

Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer

Basic Concepts in Image Based Brachytherapy (GEC-ESTRO Target Concept & Contouring)

3D ANATOMY-BASED PLANNING OPTIMIZATION FOR HDR BRACHYTHERAPY OF CERVIX CANCER

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

Basics of Cervix Brachytherapy. William Small, Jr., MD Professor and Chairman Loyola University Chicago

Carol Marquez, M.D. Department of Radiation Medicine OHSU

The Radiobiological Four "R"s of Hypofractionation. Brian Marples PhD Beaumont Health Systems

Quality management for Breast Brachytherapy.

Introduction to Radiation Biology

PRINCIPLES and PRACTICE of RADIATION ONCOLOGY. Matthew B. Podgorsak, PhD, FAAPM Department of Radiation Oncology

Collection of Recorded Radiotherapy Seminars

Radiobiological modelling applied to Unsealed Source (radio) Therapy

Predicting Maximum Pacemaker/ICD Dose in SAVI HDR Brachytherapy

Image guided brachytherapy in cervical cancer Clinical Aspects

Pulsed Dose Rate for GYN Brachytherapy

Radiobiology of fractionated treatments: the classical approach and the 4 Rs. Vischioni Barbara MD, PhD Centro Nazionale Adroterapia Oncologica

Advances in Gynecologic Brachytherapy

ISOEFFECT CALCULATION IN HDR BRACHYTHERAPY (BASIC CLINICAL RADIOBIOLOGY)

ACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER

Breast Brachytherapy: How to Allay Fears of Patients and Colleagues, and What Are Our Expectations for the Future?

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

Brachytherapy: The precise answer for tackling breast cancer. Because life is for living

ROLE OF ALTERED FRACTIONATION & CHEMORADIATION IN HEAD AND NECK CANCER

Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations*

Changing Paradigms in Radiotherapy

Limitations. General Clinical Applications of Brachytherapy Physics. Learning Objectives. Conflicts of Interest. University of Wisconsin - Madison

Assessment of dose homogeneity in conformal interstitial breast brachytherapy with special respect to ICRU recommendations

HALF. Who gets radiotherapy? Who gets radiotherapy? Half of all cancer patients get radiotherapy. By 1899 X rays were being used for cancer therapy

The New ICRU/GEC ESTRO Report in Clinical Practice. Disclosures

EMBRACE- Studien Analysen und Perspektiven

Gynecologic Vaginal Brachytherapy (Mostly Post-Op Endometrial)

Brachytherapy The use of radioactive sources in close proximity to the target area for radiotherapy

Hidden Issues in the Use of LQ. Disclosure

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

Version A European study on MRI-guided brachytherapy in locally advanced cervical cancer EMBRACE (ENDORSED BY GEC ESTRO)

Intracavitary + Interstitial Techniques Rationale

Slide 1. Slide 2. Slide 3. Introduction of INTRABEAM IORT. Disclosure. Contents. I have nothing to disclose.

Neutron Radiotherapy: Past, Present, and Future Directions

RADIOBIOLOIGCALLY BASED TREATMENT PLANNING: THE NEXT FRONTIER. Teddy LaMaster, MS

Image based Brachytherapy- HDR applications in Gynecological Tumors

Figure 1.1 PHITS geometry for PTB irradiations with: broad beam, upper panel; mono energetic beams, lower panel. Pictures of the setups and of the

Clinical outcomes of patients treated with accelerated partial breast irradiation with high-dose rate brachytherapy: Scripps Clinic experience

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO MP (CLINICAL ONCOLOGY) PART I EXAMINATION - AUGUST Time : p.m p.m.

PRINCIPLES OF RADIATION ONCOLOGY

Brachytherapy an Overview

Recent proceedings in Brachytherapy Physics

Would SBRT Hypofractionated Approach Be as Good? Then Why Bother With Brachytherapy?

Ritu Raj Upreti, S. Dayananda, R. L. Bhalawat*, Girish N. Bedre*, D. D. Deshpande

Accelerated Partial Breast Irradiation FACTS & MYTHS

presenting Brachytherapy with focus on Gynecological Cancers

A SIMPLE METHOD OF OBTAINING EQUIVALENT DOSES FOR USE IN HDR BRACHYTHERAPY

BRACHYTHERAPY IN HEAD & NECK CANCERS DR. GIRI G.V.

Radiotherapy Physics and Equipment

Recent Advances and current status of radiotherapy for cervix cancer

The temporal pattern of dose delivery in external beam radiotherapy

HDR Brachytherapy I: Overview of Clinical Application and QA. Disclosures. Learning Objectives 7/23/2014. Consultant, Varian Medical Systems

Modern Interstitial GYN Brachytherapy. Conflicts: 8/3/2016. Modern Interstitial GYN Brachytherapy. 1. Use of MR

4.1.1 Dose distributions LKB effective volume or mean liver dose? The critical volume model TUMOUR CONTROL...

Research Article A Mathematical Model of Tumor Volume Changes during Radiotherapy

Physics. Copyright 2010 Xoft, Inc.

Radiation Oncology. Initial Certification Qualifying (Computer-based) Examination: Study Guide for Radiation and Cancer Biology

BRACHYTHERAPY IN HORSES

Nitesh N. Paryani, M.D. First Radiation & Oncology Group Instructor of Radiation Oncology, Mayo Clinic Courtesy Professor, University of Florida

University of Washington, Radiation Oncology Physics Residency Program. Medical Physics Site Specific Clinical Rotation

Linking DVH-parameters to clinical outcome. Richard Pötter, Medical University of Vienna, General Hospital of Vienna, Austria

How ICD-10 Affects Radiation Oncology. Presented by, Lashelle Bolton CPC, COC, CPC-I, CPMA

Therapeutic Medical Physics. Stephen J. Amadon Jr., Ph.D., DABR

MultiSource. for a higher standard in HDR brachytherapy.

Transcription:

Clinical Applications of Brachytherapy Radiobiology Dr Alexandra Stewart University of Surrey St Luke s Cancer Centre Guildford, England Radiobiology is Essential Knowledge of radiobiological principles is essential to the brachytherapist Empirical prescription replaced by modelling Radiobiology no substitute for a badly placed Radiobiology no substitute for a badly placed implant good geometry is still key 1

Dose volume differences EBRT Volume treated is usually quite large. Variation in dose is kept minimal Homogeneous dose distribution with < 5% lower doses and < 7% higher doses BT Treated Volume is rather small Minimum dose is prescribed to an isodose encompassing the PTV Very inhomogeneous dose distribution within the treated volume 2

Gynaecologic Brachytherapy Repair The lower the dose rate of radiation, the more likely that repair will occur. PDR allows time for sublethal damage repair during treatment. HDR full normal tissue repair occurs if more than 6 24 hrs between fractions. 3

Repopulation Clear evidence of improved tumour control and survival if RT is given in shorter overall time (Perez 1995, Petereit 1995). Okkan et al 2003 average time to complete RT with HDR=70 days, with LDR=57 days. Chen et al 2003 DFS drops from 83% to 65% if overall RT time over 63 days (HDR). Reoxygenation Clear evidence of decreased survival in cervix Ca with a low initial Hb/decreased Hb during treatment PDR allows for acute hypoxia to correct during treatment. HDR allows for tumor shrinkage and reoxygenation of chronically hypoxic areas. 4

Effect of Hypoxia on Radiosensitivity OER = Oxygen Enhancement Ratio: radiation dose in hypoxia radiation dose in air Hypoxic cells Oxygenatedcells Dose [Gy] Reassortment Cells can pass out of radioresistant late S and early G 2 into moreradiosensitive radiosensitive G 2 and M during treatment. Steel, 2002 5

Dose fractionation How best to convert HDR to LDR? For cervix recommend HDR<7 Gy per fraction to achieve excellent cure with low late toxicity But in India 20 Gy in 2 fractions used with good effect Av BED doses in US IB & IIB 96 Gy 10 IIIB 100 Gy 10 Av BED doses in UK (historic) 83.3 Gy 10 Av BED doses in Vienna 100.7 Gy 10 Correlated with control! HDR BT Cervix Ca Importance offraction fraction size (to point A) Complications: < 7 Gy > 7Gy G 2 4 7.6% 11.2% G 3 4 13% 1.3% 3.4% 34% Orton, 1991 6

Accelerated Partial Breast Irradiation The variety of techniques used can demonstrate the importance ofradiobiological principles Intraoperative photons Interstitial HDR Single catheter HDR 7

The importance of radiobiology for dose START A trial was used to determine α/β ratio of breast tumour Approx 3.4 Gy Thus small changes in fraction size can produce large changes in effect of treatment Change from multi catheter interstitial to single channel MammoSite had radiobiologic implications Lots of little hotspots! One big hotspot! Courtesy David Wazer 8

Interstitial Brachytherapy Long history of use LDR doses converted to HDR using LQ equation Dose homogeneity important DHI = V100 V150/V100 Should be over 75 (over 85 ideal) Size of V150 and V200 also important BEDs and dose gradients. Dose/BED is specified at a location (reference point R) which is distant from the sources/dwell positions (S). Doses at points within the prescription isodose will therefore be higher; BEDs higher still. S x R Between R and S, dose increases according to 1/x 2. BEDs increase at an even higher rate very close to the source/dwell position BED increases according to 1/x 4. Therefore, the effective BED associated with single catheter brachytherapy applications is always higher than that determined at the dose reference point. Slide Roger Dale 9

Single catheter HDR balloon device Inhomogeneous distribution EUD concept applies In our series mean EUD 3.5Gy higher than prescribed dose Increased EUD correlated with toxicity EUD decreases with multiple dwell positions and larger bll balloon sizes DHI only favorable with very large balloons Effect of diameter and dwell positions on RB Balloon diameter (cm) Single dwell position Multiple dwell positions BED EQD2 EUD BED EQD2 EUD (Gy 3.6 ) (Gy) (Gy) (Gy 3.6 ) (Gy) (Gy) 4.0 77.9 50.1 37.9 75.4 48.5 37.1 4.5 77.7 49.9 37.9 75.1 48.3 37.0 5.0 77.4 49.8 37.8 74.8 48.1 36.9 5.5 77.2 49.6 37.7 74.5 47.9 36.8 6.0 76.9 49.5 37.6 74.2 47.7 36.7 10

Our series results for RB comparisons Tumour (Gy 3.6 ) Acute toxicity (Gy 10 ) Late toxicity (Gy 3 ) BED EQD2 EUD Mean Range Mean Range Mean Range 76.6 65.1-77.8 49.2 41.8-50.1 37.5 33.6-37.9 54.0 46.9-55.0 45.0 39.1-39.4 38.9 34.8-39.4 83.6 70.6-84.8 50.2 42.3-50.9 37.3 33.4-37.6 Intra Operative Brachytherapy LQ equation less accurate predictor at large fraction sizes When considering prescribed dose remember Single fraction has similar cell kill to 1/3 1/2 total dose of fractionated RT Increased RBE with ihphotons as energy decreases 11

Relative Effectiveness Possible Radiobiological Benefits Negates risk of accelerated repopulation No time for hypoxia to set in Geographical accuracy optimal Normal tissue protection using lead shields Possible favourable alteration of wound environment 12

Electronic Brachytherapy Electronic brachytherapy Hotter doses within treatment volume Higher V150 and V200s Spherical dose, no optimization Higher RBE at 1 cm with 50 kv x rays Lower doses beyond PTV volume 34Gy 3.4 x 10 fractions? More data needed 13

Conclusions Radiobiology is becoming increasingly important in all aspects of radiotherapy More accurate applicators and imaging gives ability for dose escalation but with due care Translational research will be important to identify who may benefit from different techniques Long term follow up is essential to determine response and toxicity 14